Clinical Trials on Epidermal p53 Expression in Netherlands
Total 122 results
-
GlaxoSmithKlineCompletedDepressive Disorder, MajorBelgium, Australia, Russian Federation, Netherlands, Norway, Finland
-
Diakonessenhuis, UtrechtAgendiaCompletedBreastcancer | Invasive Breast Carcinoma by Gene Expression ProfileNetherlands
-
Goethe UniversityKing's College London; Radboud University Medical Center; Heidelberg University; Hospital Vall d'HebronCompletedDepression | Obesity | Attention-Deficit / Hyperactivity DisorderGermany, Netherlands, Spain, United Kingdom
-
Daiichi SankyoDaiichi Sankyo Co., Ltd.Active, not recruitingNon-Small Cell Lung Cancer Metastatic | Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor ReceptorUnited States, Spain, Korea, Republic of, France, United Kingdom, Taiwan, Australia, Japan, China, Netherlands, Italy, Germany, Austria, Belgium, Bulgaria, Singapore
-
Aprea TherapeuticsCompletedPlatinum Sensitive Recurrent High-grade Serous Ovarian Cancer With Mutated p53United States, France, Spain, Netherlands, United Kingdom, Belgium, Germany, Sweden
-
Novartis PharmaceuticalsActive, not recruitingLocally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutationSpain, Italy, Austria, Netherlands, United Kingdom, Thailand, France, Belgium, China, Germany, Greece, Argentina, Turkey, Malaysia, Portugal, Brazil, United States, Hungary, India
-
P1vital Products LimitedCompletedDepressionSpain, France, Germany, United Kingdom, Netherlands
-
BRC Operations Pty. Ltd.UnknownMajor Depressive DisorderUnited States, Australia, Netherlands, New Zealand, South Africa
-
Tesaro, Inc.European Organisation for Research and Treatment of Cancer - EORTC; Breast... and other collaboratorsTerminatedOvarian Neoplasms | BRCA1 Gene Mutation | BRCA2 Gene Mutation | Neoplasms, Breast | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Carcinoma of BreastUnited States, Spain, Belgium, Israel, United Kingdom, Italy, Poland, Canada, Hungary, Netherlands, France, Portugal, Greece, Iceland
-
Eli Lilly and CompanyCompletedDepressive Disorder, MajorUnited States, Mexico, Spain, Brazil, Chile, Lithuania, Netherlands
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyEnrolling by invitationKidney Diseases | Urologic Diseases | Genetic Disease | Primary Hyperoxaluria Type 1 (PH1) | Primary Hyperoxaluria Type 2 (PH2) | Primary Hyperoxaluria Type 3 (PH3)United States, France, Germany, Japan, Lebanon, Spain, United Kingdom, Australia, Canada, Italy, Netherlands, Norway, Turkey
-
SanofiCompletedMajor DepressionBelgium, Canada, Chile, Estonia, Finland, France, Germany, Netherlands, Russian Federation, Slovakia, South Africa, Sweden
-
Eli Lilly and CompanyCompletedMajor Depressive DisorderDenmark, France, Greece, Hungary, Italy, Netherlands, Romania, Slovenia, Spain, Sweden, Turkey
-
Boehringer IngelheimCompletedDepression | Parkinson DiseaseNetherlands, Germany, Italy, Switzerland, Austria, France, Spain, United Kingdom
-
TakedaH. Lundbeck A/SCompletedMajor Depressive DisorderFrance, Ukraine, Germany, Malaysia, South Africa, Korea, Republic of, Russian Federation, Czech Republic, Lithuania, United Kingdom, Latvia, Australia, Netherlands, Poland, Taiwan
-
Janssen-Cilag International NVCompletedDepressive Disorder, MajorIsrael, Hungary, Korea, Republic of, Taiwan, Portugal, Turkey, Germany, Malaysia, Denmark, Bulgaria, Czechia, Belgium, Poland, Brazil, Netherlands, Argentina, Finland, Greece, South Africa, Austria, Kazakhstan, Norway, Sweden, United...
-
TakedaH. Lundbeck A/SCompletedMajor Depressive DisorderUnited States, France, United Kingdom, Germany, Malaysia, Serbia, South Africa, Ukraine, Taiwan, Korea, Republic of, Russian Federation, Lithuania, Latvia, Croatia, Australia, Netherlands, Poland
-
Novartis PharmaceuticalsTerminatedMajor Depressive Disorder With Suicidal Ideation With IntentTaiwan, Spain, Germany, Netherlands, Turkey, Mexico, United States, Malaysia, Poland, Canada, Japan, Russian Federation, Argentina, Brazil
-
University of ChileColumbia UniversityRecruitingDepression | Covid-19 | Anxiety | Mental Health Disorder | SARS-CoV-2 | Stress DisorderUnited States, Italy, Argentina, Armenia, Australia, Bolivia, Chile, Costa Rica, Czechia, Germany, Guatemala, Lebanon, Mexico, Netherlands, Nigeria, Puerto Rico, Saudi Arabia, Spain, Tunisia, Turkey, Venezuela
-
Boehringer IngelheimCompletedDepression | Parkinson DiseaseAustria, Finland, France, Germany, Italy, Netherlands, Norway, Romania, Russian Federation, South Africa, Spain, Sweden, Ukraine
-
AstraZenecaDaiichi Sankyo Co., Ltd.RecruitingPart 1: Bladder, Biliary Tract, Cervical, Endometrial, Ovarian, Pancreatic Cancer, Rare Tumors, Any Tumor Type Excluding Breast, Gastric, Colorectal Cancer | Part 2: HER2 Expressing/Amplified Solid Tumors Excluding Breast, Gastric, Colorectal CancerCanada, Korea, Republic of, Taiwan, United States, Italy, United Kingdom, Thailand, Russian Federation, India, Belgium, Australia, Poland, Spain, Japan, Brazil, Czechia, Netherlands
-
ExelixisRecruitingCervical Cancer | Pancreatic Cancer | Non Small Cell Lung Cancer | Triple Negative Breast Cancer | Endometrial Cancer | Epithelial Ovarian Cancer | Metastatic Castration-resistant Prostate Cancer | Hormone Receptor-positive Breast Cancer | SCCHN | Esophageal SCC | Tissue Factor-Expressing Solid TumorsUnited States, Spain, Australia, Belgium, France, Italy, Netherlands, United Kingdom, Korea, Republic of